CAI · Caris Life Sciences, Inc.
$26.27
+1.69 (+6.88%)
At close · Aug 21
Market Cap
$7.42B
Shares
282.60M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-30 | — | |
| Investor Event Transcript | 2026-06-08 | 2026-06-30 | |
| 8-K | 2026-06-05 | 2026-06-04 | |
| 10-Q | 2026-05-08 | 2026-03-31 | |
| 8-K | 2026-05-07 | — | |
| DEF 14A | 2026-04-23 | 2026-06-04 | |
| 8-K | 2026-04-02 | 2026-04-01 | |
| 10-K | 2026-03-03 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-30 | — | |
| 8-K | 2025-08-12 | — | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-06-20 | — |
Showing 1–18 of 18 filings
Key facts
CIK
2019410
CUSIP
142152107
13F (30d)
221 filings
221 filers
Visit website
Investor relations